Early research (Phase 1)Looking for participantsNCT07063693What this trial is testingABY-029 Glioma TrialWho this might be right forIntracranial Tumor Dartmouth-Hitchcock Medical Center 33
Early research (Phase 1)Study completedNCT02859857What this trial is testingPhase 1 Study of BXQ-350 in Adult Patients With Advanced Solid TumorsWho this might be right forNeoplasms Bexion Pharmaceuticals, Inc. 86
Early research (Phase 1)Study completedNCT00006246What this trial is testingBusulfan in Treating Children and Adolescents With Refractory CNS CancerWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorLeukemia+4 more Pediatric Brain Tumor Consortium 28
Early research (Phase 1)Study completedNCT05362409What this trial is testingStudy to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade GliomaWho this might be right forHigh Grade Glioma Alpheus Medical, Inc. 22
Early research (Phase 1)Ended earlyNCT00112619What this trial is testingTopotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid TumorsWho this might be right forBrain and Central Nervous System TumorsCarcinoma of Unknown PrimaryLeukemia+2 more Pediatric Brain Tumor Consortium 19
Testing effectiveness (Phase 2)Study completedNCT02490800What this trial is testingPhase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade GliomaWho this might be right forNeoplasms Basilea Pharmaceutica 72
Early research (Phase 1)Looking for participantsNCT07223034What this trial is testing177Lu-PSMA-617 in People With GliomasWho this might be right forGliomaDiffuse Astrocytoma, IDH-Wildtype (Grade 2-4)Glioblastoma, IDH-wildtype+3 more Memorial Sloan Kettering Cancer Center 20
Early research (Phase 1)Study completedNCT00946335What this trial is testingABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS TumorsWho this might be right forChildhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+25 more National Cancer Institute (NCI) 31
Not applicableStudy completedNCT00499798What this trial is testingChanges in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain TumorsWho this might be right forBrain and Central Nervous System TumorsChemotherapeutic Agent ToxicityInfertility Wake Forest University Health Sciences 16
Early research (Phase 1)Active Not RecruitingNCT07031765What this trial is testingPeds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade GliomaWho this might be right forRecurrent High-grade GliomaGrade III AstrocytomaOligodendroglioma+3 more University of Florida 12
Not applicableStudy completedNCT04212351What this trial is testingFrameshift Peptides of Children With NF1Who this might be right forNeurofibromatosis Type 1 Children's National Research Institute 60
Early research (Phase 1)Study completedNCT01076530What this trial is testingVorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord TumorsWho this might be right forChildhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Embryonal Tumor+31 more National Cancer Institute (NCI) 27
Early research (Phase 1)Study completedNCT01119599What this trial is testingRO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant GliomaWho this might be right forAcoustic SchwannomaAdult Anaplastic (Malignant) MeningiomaAdult Anaplastic Astrocytoma+26 more National Cancer Institute (NCI) 22
Early research (Phase 1)Study completedNCT00015899What this trial is testingSCH 66336 in Treating Children With Recurrent or Progressive Brain TumorsWho this might be right forBrain and Central Nervous System Tumors Pediatric Brain Tumor Consortium 53
Early research (Phase 1)Study completedNCT00053963What this trial is testingFR901228 in Treating Children With Refractory or Recurrent Solid Tumors or LeukemiaWho this might be right forBlastic Phase Chronic Myelogenous LeukemiaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00503724What this trial is testingEnzastaurin in Treating Young Patients With Refractory Primary CNS TumorsWho this might be right forBrain and Central Nervous System TumorsNeuroblastoma Pediatric Brain Tumor Consortium 32
Early research (Phase 1)Study completedNCT04430842What this trial is testingDose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SWho this might be right forAstrocytomaBrain CancerBrain Metastases+20 more Quadriga Biosciences, Inc. 15
Early research (Phase 1)Study completedNCT03603379What this trial is testingDoxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade GliomasWho this might be right forGlioblastoma University Hospital, Basel, Switzerland 9
Large-scale testing (Phase 3)Active Not RecruitingNCT04576117What this trial is testingCompare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade GliomaWho this might be right forRecurrent Low Grade AstrocytomaRecurrent WHO Grade 2 GliomaRefractory Low Grade Astrocytoma+2 more National Cancer Institute (NCI) 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT03718767What this trial is testingNivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator PhenotypeWho this might be right forGliomaGlioblastomaHigh Grade Glioma+2 more National Cancer Institute (NCI) 62